Misonix is a surgical device company that designs, manufactures, and markets innovative therapeutic ultrasonic products worldwide. The company's products are used for spine surgery, skull-based surgery, neurosurgery, cosmetic surgery, laparoscopic surgery, and other surgical applications. The combined market that the company serves is estimated to be $3 billion annually.
The company announced today that it has entered into a new, three-year, exclusive distribution agreement with Apex Medicus, which is based in Vilnius, Lithuania, for the distribution of the company's SonaStar Ultrasonic Surgical Aspirator and the BoneScapel Ultrasonic Bone Cutter. The agreement grants Apex with the right to sell products throughout the Baltic countries of Lithuania, Latvia, and Estonia.
Apex Medicus is well established in neurosurgery and skull-based surgery and has earned a reputation for successfully introducing high-tech products to the Baltic countries. The agreement between Misonix and Apex Medicus calls for Apex to purchase certain minimum amounts of SonaStar and BoneScapel annually.
The SonaStar is used by neurosurgeons and general surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. The BoneScapel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.
This agreement is another step in Misonix's plan to become a leading global provider of surgical instruments. The partnership with Apex Medicus, in the words of its CEO Michael A. McManus Jr., "fills one of our remaining coverage gaps [in Europe]."
For additional information about Misonix and all of its products, please visit the company's website at misonix.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net